Drug development
and diagnostics

Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.

Clear All
All research groups

Research Groups and R&D Platforms: Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening

Research Group:
Genetic predisposition to cancer

Johanna Schleutker
Johanna.Schleutker[at]utu.fi

Institute of Biomedicine,
University of Turku

Johanna Schleutker

Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening

Further information

Pauli Ollikka, Project Coordinator

pauli.ollikka@abo.fi
pauli.ollikka@utu.fi

Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.

Drug developmentand diagnostics

Research Group:Genetic predisposition to cancer

Further information

Drug development
and diagnostics

Research Group:
Genetic predisposition to cancer